High incidence of biallelic point mutations in Runt domain of the AML1/PEBP2αB gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21

Blood

Volumn 96, Issue 8, 2000, Pages 2862-2869

  Preudhomme, C ^a   Warot Loze, D ^a   Roumier, C ^a   Grardel Duflos, N ^a   Garand, R ^a   Lai, J L ^a   Dastugue, N ^a   Macintyre, E ^a   Denis, C ^a   Bauters, F ^a   Kerckaert, J P ^a   Cosson, A ^a   Fenaux, P ^a  

^a CHU Rouen BG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MYELOPEROXIDASE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; BLAST CELL CRISIS; CANCER GENETICS; CANCER REGRESSION; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION 12; CHROMOSOME TRANSLOCATION 21; CHROMOSOME TRANSLOCATION 3; CHROMOSOME TRANSLOCATION 8; CHRONIC MYELOID LEUKEMIA; CYTOGENETICS; DOWN SYNDROME; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE DUPLICATION; GENE EXPRESSION REGULATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MYELODYSPLASTIC SYNDROME; POINT MUTATION; PRIORITY JOURNAL; TETRASOMY; THROMBOCYTHEMIA; TRISOMY 21;

EID: 0034667690     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.8.2862     Document Type: Article

References (29)

1. The runt domain transcription factor, PEBP2/CBF, and its involvement in human leukemia
2. PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene
3. An acute myeloid leukemia gene, AML1, regulates hemopoietic myeloid cell differentiation and transcriptional activation antagonistically by two alternative spliced forms
4. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis
5. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis
6. Absence of fetal liver hematopoiesis in mice deficient in tram scriptional coactivator core binding factor beta
7. AML1 and the (8;21) and (3;21) translocations in acute and chronic myeloid leukemia
8. ETV6 is the target of chromosome 12p deletions in t(12; 21) childhood acute lymphoblastic leukemia
9. Negative regulation of granulocytic differentiation in the myeloid precursor cell line 32 Dcl3 by ear-2, a mammalian homolog of Drosophila seven-up, and a chimeric leukemogenic gene, AML1/ETO(MTG8)
10. Synergistic up-regulation of the myeloid-specific promoter for the macrophage colony-stimulating factor receptor by AML1 and the (8;21) fusion protein may contribute to leukemogenesis
11. The t(12; 21) translocation converts AML-1B from an activator to a repressor of transcription
12. Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2αB gene associated with myeloblastic leukemias
13. Proposals for the classification of acute leukemias, a report of the French-American-British Cooperative Group
14. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO)
15. The t(12;21) of acute lymphoblastic leukemia results in a TEL-AML1 gene fusion
16. The 12;21 translocation involving TEL and deletion of the other TEL allele: Two frequently associated alterations found in childhood acute lymphoblastic leukemia
17. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction
18. Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products
19. Analysis of chromosome 21 copy number in uncultured amniocytes by fluorescence in situ hybridization using a cosmid contig
20. Haplo-insufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia
21. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma
22. Duplication and overexpression of the mutant allele of the MET proto-oncogene in multiple hereditary papillary renal cell tumors
23. Evidence for two molecular steps in the pathogenesis of myeloid disorders associated with deletion of chromosome 7 long arm
24. Chromosome loss with concomitant duplication and recombination both contribute most to loss of heterozygosity in vitro
25. Runt domains take the lead in hematopoiesis and osteogenesis
26. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia
27. Immunoglobulin motif DNA recognition and heterodimerization of the PEBP2/CBF Runt domain
28. Functional dissection of the alpha et beta subunits of transcription factor PEBP2 and the redox susceptibility of its DNA binding activity